D. Altman, L. McShane, W. Sauerbrei, and S. Taube. PLoS medicine, 9 (5):
e1001216(January 2012)6692<m:linebreak></m:linebreak>M3: doi:10.1371/journal.pmed.1001216;<m:linebreak></m:linebreak>Publicació.
D. Altman, and D. Moher. BMJ (Clinical research ed.), (January 2013)7500<m:linebreak></m:linebreak>JID: 8900488; OID: NLM: PMC3737035; epublish;<m:linebreak></m:linebreak>Publicació.
M. Angell. JAMA : the journal of the American Medical Association, 300 (9):
1069-71(September 2008)4723<m:linebreak></m:linebreak>JID: 7501160; ppublish;<m:linebreak></m:linebreak>Recursos/Organització; Recerca clínica.
G. Apolone. Health and quality of life outcomes, (January 2003)5220<m:linebreak></m:linebreak>JID: 101153626; 0 (Antineoplastic Agents); OID: NLM: PMC155672; 2003/02/27 received; 2003/04/03 accepted; 2003/04/03 aheadofprint; epublish;<m:linebreak></m:linebreak>Mesures de resultats.
M. Barza, T. Trikalinos, and J. Lau. Infectious disease clinics of North America, 23 (2):
195-210, Table of Contents(June 2009)5145<m:linebreak></m:linebreak>JID: 8804508; RF: 57; ppublish;.
N. Bass, A. Vos, and S. Woodgate. Annals of the Academy of Medicine, Singapore, 36 (9):
760-4(September 2007)5034<m:linebreak></m:linebreak>JID: 7503289; ppublish;<m:linebreak></m:linebreak>Recursos/Organització; Formació.